Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AnaptysBio Inc.
DescriptionAnti-IL-33 antibody
Molecular Target Interleukin-33 (IL-33) (NF-HEV)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today